ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716260 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716260; 2) Community: the network communities that were significantly associated with the response to NSC 716260; 3) Molecule: the relationships between components within communities and NSC 716260; 4) MDR: the compounds that were significantly associated with the NSC 716260.

NSC Compound Enrichment Correlation
NSC 703763 Null 0.0467178916101838 0.13620355
NSC 704113 Null 0.0467178916101838 0.25802575
NSC 708387 Null 0.0467178916101838 0.23329821
NSC 711014 Null 0.0467178916101838 0.20708616
NSC 715664 Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- 0.0467178916101838 0.26523983
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.0467178916101842 0.12313948
NSC 724771 Null 0.0467178916101842 0.25137876
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0467178916101842 -0.0063700265
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0467178916101842 0.2207824
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0467178916101842 0.19458864
Total:142  Current:138    [First] [Prev] [Next] [Last]